Network origin in Andy Hu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andy Hu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| MEDICINOVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Viveve, Inc.
 Viveve, Inc. Medical SpecialtiesHealth Technology Viveve, Inc. engages in the development of medical devices that promote personal health and wellness. It offers InControl products and Viveve system solutions. The company was founded by Jonathan B. Parmer in 2005 and is headquartered in Englewood, CO. | Medical Specialties | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Chief Executive Officer | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Carlow College | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| Western New England University | College/University | Undergraduate Degree | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
| MUSC Foundation for Research Development | Director/Board Member | ||
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chairman | |
Humane Society of Silicon Valley
 Humane Society of Silicon Valley Miscellaneous Commercial ServicesCommercial Services The Humane Society of Silicon Valley provides animal welfare services. The non-profit company is based in Milpitas, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Medical University of South Carolina Foundation
 Medical University of South Carolina Foundation Investment Trusts/Mutual FundsMiscellaneous Medical University of South Carolina Foundation engages in the provision of educational foundation. It supports the education, research, patient care, and other programs at the Medical University. The company was founded in 1966 and is headquartered in Charleston, SC. | Investment Trusts/Mutual Funds | Chairman | |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
| Carlow University Of | College/University | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree | |
| VIVEVE MEDICAL, INC. | Medical Specialties | Director/Board Member | |
IONpath, Inc.
 IONpath, Inc. Medical/Nursing ServicesHealth Services IONpath, Inc. transforms pathology with multiplexed ion beam imaging. The company was founded by Michael Angelo, Sean Bendall, Harris Fienberg and Gerry Noland and is headquartered in San Mateo, CA. | Medical/Nursing Services | Director/Board Member | |
Neovacs, Inc.
 Neovacs, Inc. Pharmaceuticals: MajorHealth Technology Neovacs, Inc. operates as a biotechnology company. It focuses on an active immunotherapy technology platform with applications in autoimmune and inflammatory diseases. The company was founded on March 3, 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Willow Advisors LLC
 Willow Advisors LLC Miscellaneous Commercial ServicesCommercial Services Willow Advisors LLC provides consulting services. The private company is based in Berkeley. Arlene M. Morris has been the CEO of the American company since 2015. | Miscellaneous Commercial Services | Chief Executive Officer | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Director/Board Member | |
| NKARTA, INC. | Biotechnology | Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Charleston Animal Society
 Charleston Animal Society Miscellaneous Commercial ServicesCommercial Services Charleston Animal Society is an American company that offers pet insurance. The non-profit company is located in the US. The company is recommended by the Dodo, which is the #1 animal brand in the world. | Miscellaneous Commercial Services | Director/Board Member | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| TC BIOPHARM (HOLDINGS) PLC | Biotechnology | Chairman | |
| Clearview Projects, Inc. | Chief Executive Officer |
Statistics
International
| United States | 47 |
| France | 3 |
| Belgium | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 33 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Health Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 103 |
| Independent Dir/Board Member | 47 |
| Chairman | 32 |
| Corporate Officer/Principal | 25 |
| Chief Executive Officer | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Georges Gemayel | 33 |
| Alan Colowick | 30 |
| Arlene Morris | 28 |
| Donald Hayden | 23 |
| John Hohneker | 19 |
| George Migausky | 18 |
| Michael Dybbs | 17 |
| Jean Franchi | 17 |
| Alex Fotopoulos | 7 |
- Stock Market
- Insiders
- Andy Hu
- Company connections
